Neurotez Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Crowdfunding

  • Financing Rounds
  • 8

Neurotez General Information

Description

Operator of a biopharmaceutical company intended to serve Alzheimer's patients characterized by hyperleptinemia. The company offers screening, identification and characterization of treatments using biochemical, molecular and cell biology in vivo models, enabling medical practitioners to improve the lives of their patients and serve the public responsibly.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • 991 Highway 22
  • Suite 200A
  • Bridgewater, NJ 08807
  • United States
+1 (908)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 991 Highway 22
  • Suite 200A
  • Bridgewater, NJ 08807
  • United States
+1 (908)

Neurotez Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Neurotez Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Neurotez‘s full profile, request access.

Request a free trial

Neurotez Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biopharmaceutical company intended to serve Alzheimer's patients characterized by hyperleptinemia. The com
Drug Discovery
Bridgewater, NJ
7 As of 2023

Singapore, Singapore
 

Newark, NJ
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Neurotez Competitors (12)

One of Neurotez’s 12 competitors is Cerecin, a Venture Capital-Backed company based in Singapore, Singapore.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cerecin Venture Capital-Backed Singapore, Singapore
Cellix Bio Venture Capital-Backed Newark, NJ
Ability Pharma Private Equity-Backed Barcelona, Spain
Centrexion Therapeutics Venture Capital-Backed Boston, MA
Bristol-Myers Squibb Corporation Princeton, NJ
You’re viewing 5 of 12 competitors. Get the full list »

Neurotez Patents

Neurotez Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20140088000-A1 Leptin rescues neurons from alzheimer's disease related pathways triggered by lipid burden Inactive 27-Sep-2012
US-20130065825-A1 Compositions and methods for delaying senescence or cell death in neurons Inactive 14-Sep-2011
US-20120231457-A1 Compositions and methods for assessing a genetic risk of developing late-onset alzheimer's disease (load) Inactive 10-Mar-2011
AU-2009313562-A1 Leptin compositions and methods for treating progressive cognitive function disorders resulting from accumulation of neurofibrillary tangles and amlyoid beta Active 04-Nov-2008
AU-2009313562-B2 Leptin compositions and methods for treating progressive cognitive function disorders resulting from accumulation of neurofibrillary tangles and amlyoid beta Inactive 04-Nov-2008 A61K38/22
To view Neurotez’s complete patent history, request access »

Neurotez Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Neurotez Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Neurotez‘s full profile, request access.

Request a free trial

Neurotez FAQs

  • When was Neurotez founded?

    Neurotez was founded in 2005.

  • Where is Neurotez headquartered?

    Neurotez is headquartered in Bridgewater, NJ.

  • What is the size of Neurotez?

    Neurotez has 7 total employees.

  • What industry is Neurotez in?

    Neurotez’s primary industry is Drug Discovery.

  • Is Neurotez a private or public company?

    Neurotez is a Private company.

  • What is Neurotez’s current revenue?

    The current revenue for Neurotez is .

  • How much funding has Neurotez raised over time?

    Neurotez has raised $150M.

  • Who are Neurotez’s investors?

    CRG Capital Partners, U.S. Department of Health and Human Services, and National Institutes of Health have invested in Neurotez.

  • Who are Neurotez’s competitors?

    Cerecin, Cellix Bio, Ability Pharma, Centrexion Therapeutics, and Bristol-Myers Squibb are some of the 12 competitors of Neurotez.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »